Standard Therapy for Glioblastoma : A Review of Where We Are

スポンサーリンク

概要

• 論文の詳細を見る

• Glioblastoma is the most common primary malignant brain tumor in adults and is a challenging disease to treat. The current standard therapy includes maximal safe surgical resection, followed by a combination of radiation and chemotherapy with temozolomide. However, recurrence is quite common, so we continue to search for more effective treatments both for initial therapy and at the time of recurrence. This article will review the current standard of care and recent advances in therapy for newly-diagnosed and recurrent glioblastomas, based on the most authoritative guidelines, the National Cancer Institute's comprehensive cancer database Physician Data Query (PDQ®), and the National Comprehensive Cancer Network Clinical Practice Guidelines in OncologyTM for central nervous system cancers (V.1.2010), to elucidate the current position and in what direction we are advancing.

• 社団法人　日本脳神経外科学会の論文
• 2010-09-15

著者

• Nishikawa Ryo

  Department Of Chemistry Graduate School Of Science Kyoto University

• Nishikawa Ryo

  Department Of Neuro-oncology/neurosurgery International Medical Center Saitama Medical University

関連論文

• Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas : first study in Asians
• Iron-catalyzed Oxidative Coupling of Alkylamines with Arenes, Nitroalkanes, and 1,3-Dicarbonyl Compounds
• Standard Therapy for Glioblastoma : A Review of Where We Are
• Central Nervous System Lymphoma Initially Diagnosed as Tumefactive Multiple Sclerosis after Brain Biopsy
• Ring-shaped Lateral Ventricular Nodules Detected with Brain MR Imaging
• A Multicenter Phase I/II Study of the BCNU Implant (Gliadel® Wafer) for Japanese Patients with Malignant Gliomas

スポンサーリンク